Skip to main content
PLOS One logoLink to PLOS One
. 2012 May 24;7(5):e37889. doi: 10.1371/journal.pone.0037889

Professional Exposure to Goats Increases the Risk of Pneumonic-Type Lung Adenocarcinoma: Results of the IFCT-0504-Epidemio Study

Delphine Lutringer-Magnin 1,2,3,4,#, Nicolas Girard 1,2,3,5,#, Jacques Cadranel 6, Caroline Leroux 2,3,5, Elisabeth Quoix 7, Vincent Cottin 1,2,3,5, Corinne Del Signore 2,3,4, Marie-Paule Lebitasy 8, Geneviève Cordier 2,3,5, Philippe Vanhems 1,2,3,4,, Jean-François Mornex 1,2,3,5,¶,*
Editor: Brock C Christensen9
PMCID: PMC3360000  PMID: 22655078

Abstract

Pneumonic-type lung adenocarcinoma (P-ADC) represents a distinct subset of lung cancer with specific clinical, radiological, and pathological features. Given the weak association with tobacco-smoking and the striking similarities with jaagsiekte sheep retrovirus (JSRV)-induced ovine pulmonary adenocarcinoma, it has been suggested that a zoonotic viral agent infecting pulmonary cells may predispose to P-ADC in humans. Our objective was to explore whether exposure to domestic small ruminants may represent a risk factor for P-ADC. We performed a multicenter case-control study recruiting patients with P-ADC as cases and patients with non-P-ADC non-small cell lung cancer as controls. A dedicated 356-item questionnaire was built to evaluate exposure to livestock. A total of 44 cases and 132 controls were included. At multivariate analysis, P-ADC was significantly more associated with female gender (Odds-ratio (OR) = 3.23, 95% confidence interval (CI): 1.32–7.87, p = 0.010), never- smoker status (OR = 3.57, 95% CI: 1.27–10.00, p = 0.015), personal history of extra-thoracic cancer before P-ADC diagnosis (OR = 3.43, 95% CI: 1.10–10.72, p = 0.034), and professional exposure to goats (OR = 5.09, 95% CI: 1.05–24.69, p = 0.043), as compared to other subtypes of lung cancer. This case-control suggests a link between professional exposure to goats and P-ADC, and prompts for further epidemiological evaluation of potential environmental risk factors for P-ADC.

Introduction

Lung cancer is the leading cause of cancer-related death worldwide, and is related to cigarette smoking in the majority of patients. However, the disease also arises in individuals who are never or little smokers, then mostly presenting with adenocarcinoma-type histology [1], [2]. Among these tumours, pneumonic-type adenocarcinoma (P-ADC) represents a subset with a distinct pathological and radiological presentation and a specific clinical course: higher female: male ratio, lower relationship with tobacco smoking, predominant lepidic growth, diffuse alveolar consolidation [3], [4]. The carcinogenesis of this tumour entity is poorly understood.

Ovine pulmonary adenocarcinoma is a naturally occurring lung cancer that arises in sheep infected by jaagsiekte sheep retrovirus (JSRV) [5][7]. It has been described for a long time as an animal model for human P-ADC, as the two tumours share strikingly similar clinical, radiological and pathological features [7], [8]. Animals with ovine pulmonary adenocarcinoma present with progressive dyspnea, abundant bronchorrhea, cough, anorexia and cachexia. As in its human counterpart, lesions present as multiple disseminated nodules and consolidation of variable size, with a morphologic pattern of adenocarcinoma with predominant lepidic growth. Both diseases originate from alveolar type II and Clara cells, although P-ADC may also contain bronchiolar mucoid cells [6].

A viral etiology of P-ADC has been suggested for years. Results are still conflicting [9], [10], but no direct biological evidence of a specific role for any retrovirus has been reported in human P-ADC so far. In this study, we approached this question from an epidemiological point of view. We hypothesized that, given the absence of - or the lower - direct exposure to known carcinogens, patients with P-ADC may represent a subgroup for which a viral agent, possibly related to JSRV and infecting pulmonary cells, may predispose to cancer. As previous attempts to detect viruses from human P-ADC have been largely unsuccessful, we undertook a case-control approach to determine whether exposure to domestic small ruminants might represent a risk factor for P-ADC in humans.

Methods

Study participants

This study was conducted as an ancillary study of two prospective phase II trials evaluating as first-line treatment of P-ADC the efficacy of gefitinib (IFCT-0401; clinicaltrialsID: NCT00198380) and the comparison of two strategies erlotinib vs. carboplatine paclitaxel (IFCT-0504; clinicaltrialsID: NCT00384826) [11].

The present case-control study aimed at determining whether chronic exposure to domestic small ruminants may increase the risk factor of P-ADC compared to other lung cancers. A case-control design was used given the low incidence of the disease. Participants were prospectively recruited in 11 regional university hospitals from January 2004 to March 2008. All centers used the same study design. Cases were consecutive patients, who consulted during the study period for prevalent or incident P-ADC, as defined based upon radiological-pathological criteria [3], including 1) histologically or cytologically-proven lung adenocarcinoma with predominant lepidic growth, i.e. bronchioloalveolar carcinoma or adenocarcinoma with bronchioloalveolar features according to the 2004 World Health Organisation classification [12], 2) multiple bilateral consolidations possibly showing air bronchogram at chest computed tomography, in the absence of pulmonary infection, 3) no endobronchial macroscopic lesion, and 4) no extra-thoracic metastases. Exclusion criteria were 1) lobar or complete lung atelectasis, and 2) personal history of extra-thoracic cancer in the 5 years prior to P-ADC diagnosis.

Three controls, i.e. one patient with non-P-ADC lung adenocarcinoma and two patients with non-adenocarcinoma-type non-small cell lung cancer, were recruited for each case. This design was chosen to address potential bias related to common risk factors both for lung adenocarcinoma and furthermore lung cancer, including tobacco smoking. Controls had to be recruited within a 6-month period in the same hospital department as cases and were not matched with cases regarding gender, age, or tobacco-smoking history.

All patients provided written informed consent before enrollment. The regional ethics committee of the Hospices Civils de Lyon and local institutional review boards of participating institutions approved the study.

Data collection

Data were collected using a dedicated 356-item questionnaire (available in french upon request) that was administrated by the physician in charge of the patient during a face-to-face interview. A written protocol was set up to ensure standardization in the procedures to collect data. The questionnaire addressed the frequency, the type (professional or leisure), and the age-period (0–12, 13–20, 21–40 and >40 years-old) of contacts, and the domestic animals (family and species) the patient was exposed to: (1) Bovidae that include sheep (Ovis aries), goats (Capra hircus), and cattle (Bos taurus), (2) Equidae especially horses (Equus caballus), donkeys (Equus asinus), (3) Suidae with pigs (Sus scrofa), (4) Leporidae with rabbits (Oryctolagus cuniculus) (5) Phasianidae, with domestic chickens (Gallus gallus) and turkeys (Meleagris gallopavo), and (6) Anatidaed, especially ducks (Anas platyrhynchos) and geese (Anser domesticus). If significant contact was identified, more detailed data were collected using a pre-established list of closed questions: What was the patient occupation? How many animals were in the farm? Did the farm experience epidemic infection? Did the patient personally participate in the feeding/milking/care/slaughtering processes? Was the patient exposed to animal blood, viscera, or fetal tissue? Collected data also included demographics, county of residency and frequency of country stay, detailed smoking history, including second-hand tobacco exposure, alcohol consumption, job history, environmental exposures, and complete personal and familial medical history, especially of cancer and pulmonary non-neoplastic disease. Never smokers were defined as individuals who smoked less than 100 cigarettes in a lifetime. Little smokers were individuals who had a tobacco-consumption history lower than 15 pack-years.

Statistical methods

Categorical variables were compared using the Chi-2 test and continuous variables using the Student's test. Multivariate logistic regression was used to determine variables independently associated with P-ADC vs. other lung cancers (entry p<0.15). Results were considered significant at the 0.05 levels. Independent variables were selected using a backward selection technique based on the likelihood ratio test, using the SPSS software program (Chicago, IL), version 17. Preliminary data suggested that about 30% of French individuals >40 years old have been exposed to domestic small ruminants. A group-sequential method, based on a triangular test, was used to calculate the number of patients to include. We estimated that 42 cases and 126 controls would allow 85% power to detect a 6-fold increase in the risk of P-ADC in patients exposed to domestic small ruminants.

Results

Study population

A total of 44 patients with P-ADC (cases) were interviewed and completed the questionnaire. We were able to recruit 132 control patients, including 44 patients with non-P-ADC lung adenocarcinoma and 88 patients with non-adenocarcinoma-type non-small cell lung cancer. Population characteristics are shown in Table 1. As expected in France, the majority of patients were Caucasian (88% of cases and 94% of controls; p = 0.310). As required in the study protocol for each individual case, all controls were recruited at the same medical center.

Table 1. Population characteristics.

Casesn = 44 (%) Controlsn = 132 (%) P
Demographic data
Gender
 Male 20 (45) 103 (78) <0.001
 Female 24 (55) 29 (22)
Smoking history
 Smoker 27 (61) 121 (92) 0.001
 Never-smoker 17(39) 11 (8)
Pack-years
 0 17 (39) 12 (9) <0.001
 1–25 15 (34) 28 (21)
 26–50 9 (20) 46 (35)
 >50 3 (7) 46 (35)
Personal and family history
Lung diseases
 No 29 (76) 86 (65) 0.928
 Yes 15 (24) 46 (35)
X-Ray exposure
 No 41 (93) 128 (97) 0.265
 Yes 3 (7) 4 (3)
Personal history of cancer
 No 36 (82) 122 (92) 0.080
 Yes 8 (18) 10 (8)
Family history of lung cancer
 No 42 (95) 115 (87) 0.123
 Yes 2 (5) 17 (13)

Case (P-ADC) and control (non-P-ADC) groups were compared using univariate analysis with the Chi-2 test.

Univariate analysis showed that cases were more frequently women (p<0.001), and never- or little-smokers than controls (p = 0.001 and p<0.001, respectively). There was no significant difference between cases and controls regarding mean age at tumour onset (64 and 60 years-old, respectively; p = 0.112), frequency and type of concurrent non-neoplastic lung disease (p = 0.928), X-ray chronic exposure (p = 0.265), personal history of cancer more than 5 years before P-ADC diagnosis (p = 0.080), or family history of lung cancer (p = 0.123).

Exposure to livestock

To ensure an optimal coverage of activities linked with exposure to livestock, we collected data about the frequency, the age period, the leisure and/or professional setting, and the type of animals the patients with lung cancer had contacts with (Table 2). Overall, 34% of individuals of the cohort had contact with domestic small ruminants. Univariate analysis did not identify any significant differences in leisure-related variables among cases and controls (Table 2); of note, exposure during childhood (either 0–12 years or 13–20 years) was not different between the two groups.

Table 2. Exposure to livestock in the study population.

Casesn = 44 (%) Controlsn = 132 (%) P
Leisure exposure
Animals
Sheep 9 (20.5) 31 (23.5) 0.644
Goats 19 (43.2) 47 (35.6) 0.369
Poultry 25 (56.8) 70 (53.0) 0.662
Cows 16 (36.4) 53 (40.2) 0.631
Pigs 12 (27.3) 37 (28.0) 0.923
Horses 11 (25.0) 25 (18.9) 0.394
Rabbits 23 (52.3) 65 (49.2) 0.728
Frequency/Age (≥1 country stay per week)
0–12 years-old 15 (34.1) 57 (43.2) 0.288
12–20 years-old 13 (29.5) 53 (40.2) 0.208
20–40 years-old 12 (27.3) 33 (25.0) 0.765
>40 years-old 9 (20.5) 35 (26.5) 0.421
≥1 family member farmer, shepherd or breeder 19 (43.2) 52 (39.4) 0.657
Professional exposure
Occupation
Farmer 6 (13.6) 33 (25.0) 0.352
Breeder 3 (6.8) 15 (11.4) 0.567
Shepherd 0 4 (3.0) 0.573
Butcher 2 (4.5) 1 (0.8) 0.155
Laboratory worker 0 1 (0.8) 1
Type of animals
Sheep 3 (6.8) 9 (6.8) 1
Goats 4 (9.1) 4 (3.0) 0.095
Poultry 4 (9.1) 19 (14.4) 0.366
Cows 3 (6.8) 21 (15.9) 0.128
Pigs 1 (2.3) 13 (9.8) 0.194
Horses 5 (11.4) 9 (6.8) 0.343
Rabbits 0 (0) 0 (0) -

Case (P-ADC) and control (non-P-ADC) groups were compared using univariate analysis with the Chi-2 test.

Conversely, even if the type of occupation was not identified as a significant variable, exposure to goats tended to be more frequent in cases vs. controls (9% vs. 3%, respectively; p = 0.095). Using all the informations collected, we then looked into details of the professional activities; despite the potential limitation of limited size of the groups, there was a trend for cases to be more frequently involved in the processes of goat feeding (9% vs. 3% in controls; p = 0.112), care (9% vs. 2%; p = 0.032), and litter (7% vs. 2%; p = 0.173) processes. No significant difference in the age of exposed cases and controls was identified. However, living in the same household as an individual working with domestic small ruminants did not increase the risk of P-ADC (p = 0.657).

Association analyses

The following variables identified at univariate analysis to potentially be associated with P-ADC when compared to non-P-ADC were included in the multivariate analysis model: age, gender, smoking status and pack-years, personal history of extra-thoracic cancer more than 5 year before P-ADC, and professional exposure to goats.

Overall, the analysis confirmed that P-ADC was significantly more associated with female gender (Odds-ratio (OR) = 3.23, 95% confidence interval (CI): 1.32–7.87, p = 0.010), never- smoker status (OR = 3.57, 95% CI: 1.27–10.00, p = 0.015), personal history of extra-thoracic cancer (OR = 3.43, 95% CI: 1.10–10.72, p = 0.034), and professional exposure to goats (OR = 5.09, 95% CI: 1.05–24.69, p = 0.043), as compared to non-P-ADC lung cancer (Table 3).

Table 3. Factors independently associated with pneumonic-type lung adenocarcinoma.

Casesn = 44 (%) Controlsn = 132 (%) Odds-Ratio [CI 95%] P
Gender
Male 20 (45) 103 (78) 1
Female 24 (55) 29 (22) 3.23 1.32–7.87 0.010
Smoking status
Smoker 27 (61) 121 (92) 1
Never smoker 17(39) 11 (8) 3.57 1.27–10 0.015
Personal history of cancer
No 36 (82) 122 (92) 1
Yes 8 (18) 10 (8) 3.43 1.10–10.72 0.034
Professional exposure to goats
No 40 (81) 128 (97)
Yes 4 (9) 4 (3) 5.09 1.05–24.69 0.043

Multivariate analysis was performed using log regression model including significant variables at univariate analysis with p<0.15.

CI: Confidence Interval.

Discussion

The identification of environmental risk factors that may predispose to lung cancer requires a deep analysis of leisure and professional activities in specific subgroups of patients for whom tobacco smoking may not represent a major carcinogen. In this study, we show that case-control study is an appropriate approach to assess potential associations between P-ADC and exposure to domestic small ruminants, as previous virology studies have failed to isolate a causal infectious agent.

We were able to recruit the planned number of cases and controls in a reasonable timeframe for a rare disease. Moreover, using this approach, our results suggest that, among non-small lung cancers, P-ADC may occur more frequently in patients exposed to goats in an occupational setting, with an OR of 5.1 that is significantly higher than those previously reported for most of the non-tobacco-related risk factors for lung cancer such as 1.3 to 1.4 for diesel exhaust exposure, 1.1 to 1.3 for coffee consumption, and 1.3 to 1.7 for silica exposure [13][15].

P-ADC is a rare tumour, which corresponds to a specific clinical-radiological-pathological entity within lung adenocarcinomas [3], [4]. From a pathological perspective, P-ADC is frequently classified as diffuse mucinous bronchioloalveolar carcinoma [3], [16], [17]. Higher female: male ratio, higher number of never- or little-smokers, and higher frequency of previous cancer were associated with an increased risk of P-ADC as compared to other subtypes of lung cancer, as previously reported [3], [16][22]. The latest findings suggest that genetic susceptibility plays a significant role in the carcinogenesis of P-ADC, as highlighted by recent genome-wide association studies conducted in never-smokers [23]. The clinical characteristics of our cohort of cases were thus very similar to that of previously reported series of patients with P-ADC, therefore suggesting our findings regarding exposure to domestic small ruminants to be relevant.

Some limitations of our analysis must be addressed. First, as in any case-control studies, a memory bias could have occurred for the cases. In our study, the fact that controls, as well as cases, were sick patients and thus had to do a similar memory effort to remember past exposures may have partially controlled this bias. Secondly, we identified a risk factor between patients with different types of lung cancers, namely P-ADC vs. other lung carcinomas, but not vs. healthy controls. The statistical power of our analysis would be improved with a larger sample size, facilitating identification of additional interactions and comparison to other risk factors previously identified. However, feasibility may be limited by the rarity of P-ADC. Finally, Epidermal Growth Factor Receptor (EGFR) mutations, which are major oncogenic drivers in lung carcinoma tumours exhibiting predominant lepidic growth [24], were not assessed, as collection of biological materials was not included in the design of the 2 associated trials, which were designed before these mutations were discovered.

The rationale supporting a potential association between P-ADC and exposure to goats is not fully understood. Besides a potential exposure of farmers to chemical carcinogens found in artificial fertilizers –that was not recorded in our study-, our baseline hypothesis was that morphological similarities between JSRV-related ovine pulmonary carcinoma and human P-ADC suggest a role for a zoonotic agent, such as JSRV or JSRV-related virus infection playing a role in human cancer induction [7], [8]. Identifying a more frequent exposure to sheep in patients with P-ADC would have further supported this hypothesis. An association with goat exposure was not anticipated. However, our findings prompt further research studies towards caprine specific infectious agents, including enzootic nasal tumor virus (ENTV), a beta retrovirus closely related to JSRV and responsible for an ethmoid tumour in goats associated with the transformation of nasal epithelial cells [25]. JSRV and ENTV are two closely related viruses having many biological features in common. Further supporting this hypothesis, meat workers have already been reported to harbor a higher risk of cancer [26].

Hyaluronidase type 2 (HYAL2) is the ubiquitous receptor for both the JSRV and ENTV envelope glycoproteins. HYAL2 is expressed at the cell surface and mediates infection by retroviral vectors pseudotyped with the JSRV or ENTV envelope proteins [27][29]. Several studies have explored the possible link between retroviruses of the JSRV family and human lung adenocarcinoma [9], [27], [30][33]. An immunohistochemistry study suggested that a JSRV-related capsid protein might be expressed in about 30% of human bronchioloalveolar carcinomas, and 26% of lung adenocarcinoma tumours [30]. Endogenous JSRV DNA sequences, integrated counterparts of the exogenous JSRV, have been detected in bronchioloalveolar tumor tissues from Sardinian patients [31], as well as in the blood from African patients without lung tumours [32]. Other studies using more specific PCR-based analyses failed to detect any exogenous or endogenous JSRV or beta retrovirus related sequences in human adenocarcinoma [9], [33]. These data discussing a role for JSRV in human lung cancer have yet to be further validated. In this respect, this first epidemiological study gives encouraging signal to continue to assess a viral component in P-ADC. Of note, a recent report suggested that Human T-cell Lymphotropic Virus type I, a member of the retrovirus family related to JSRV and ENTV, may represent a risk factor for bronchioloalveolar carcinoma [10].

To conclude, this study suggests an independent link between goat exposure and P-ADC. As the biological mechanisms supporting such association remain unknown, these results should be considered as hypothesis-generating, and prompt for further epidemiological studies especially in a more selected population: never- or little-smokers, living in the countryside, possibly in JSRV/ENTV endemic regions, and working with domestic small ruminants. Better quantification of animal exposure is also needed, similarly to earlier studies conducted with carcinogens [34]. Meanwhile, environmental questionnaire might be included in clinical studies enrolling patients with P-ADC.

Acknowledgments

We thank the French Intergroup of Thoracic Oncology (IFCT) for supporting the study and the following investigators for enrolling patients in decreasing number of inclusions: Gérard ZALCMAN (Caen Hospital), Dominique PAILLOTIN (Bois-Guillaume Hospital), Julien CASTEIGT (Dieppe Hospital), Yannick LE GUEN (Angers Hospital), Virginie WESTEEL (Besançon Hospital), Stéphane CHOUABE (Charleville-Mezières Hospital), Philippe MASSON (Cholet Hospital), Isabelle MONNET (Créteil Hospital), and Julien MAZIERES (Toulouse Hospital).

Footnotes

Competing Interests: The authors have declared that no competing interests exist.

Funding: This study was supported by grants from Institut National de la Recherche 304 Agronomique (EpiEmerge), Université Lyon 1 (Bonus Qualité Recherche) and Institut 305 National du Cancer (unité pilote de coordination pour la prise en charge des tumeurs 306 malignes rares intrathoraciques de l'adulte). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Wakelee HA, Chang ET, Gomez SL, Keegan TH, Feskanich D, et al. Lung cancer incidence in never smokers. J Clin Oncol. 2007;25:472–478. doi: 10.1200/JCO.2006.07.2983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Koo LC, Ho JH. Worldwide epidemiological patterns of lung cancer in nonsmokers. Int J Epidemiol. 1990;19:S14–S23. doi: 10.1093/ije/19.supplement_1.s14. [DOI] [PubMed] [Google Scholar]
  • 3.Wislez M, Massiani MA, Milleron B, Souidi A, Carette MF, et al. Clinical characteristics of pneumonic-type adenocarcinoma of the lung. Chest. 2003;123:1868–1877. doi: 10.1378/chest.123.6.1868. [DOI] [PubMed] [Google Scholar]
  • 4.Garfield DH, Cadranel JL, Wislez M, Franklin WA, Hirsch FR. The bronchioloalveolar carcinoma and peripheral adenocarcinoma spectrum of diseases. J Thorac Oncol. 2006;1:344–359. [PubMed] [Google Scholar]
  • 5.Leroux C, Girard N, Cottin V, Greenland T, Mornex JF, et al. JSRV (jaagsiekte sheep retrovirus): from virus to lung cancer in sheep. Vet Res. 2007;38:211–228. doi: 10.1051/vetres:2006060. [DOI] [PubMed] [Google Scholar]
  • 6.Griffiths DJ, Martineau HM, Cousens C. Pathology and pathogenesis of ovine pulmonary adenocarcinoma. J Comp Pathol. 2010;142:260–283. doi: 10.1016/j.jcpa.2009.12.013. [DOI] [PubMed] [Google Scholar]
  • 7.Mornex JF, Thivolet F, De las Heras M, Leroux C. Pathology of human bronchioloalveolar carcinoma and its relationship to the ovine disease. Curr Top Microbiol Immunol. 2003;275:225–248. doi: 10.1007/978-3-642-55638-8_9. [DOI] [PubMed] [Google Scholar]
  • 8.Marcq M, Galy P. Bronchioloalveolar carcinoma. Clinicopathologic relationships, natural history, and prognosis in 29 cases. Am Rev Respir Dis. 1973;107:621–629. doi: 10.1164/arrd.1973.107.4.621. [DOI] [PubMed] [Google Scholar]
  • 9.Hopwood P, Wallace WA, Cousens C, Dewar P, Muldoon M, et al. Absence of markers of betaretrovirus infection in human pulmonary adenocarcinoma. Human Pathol. 2010;41:1631–1640. doi: 10.1016/j.humpath.2010.05.013. [DOI] [PubMed] [Google Scholar]
  • 10.Nomori H, Mori T, Iyama K, Okamoto T, Kamakura M. Risk of Bronchioloalveolar Carcinoma in Patients with Human T-cell Lymphotropic Virus Type 1 (HTLV-I): Case-control Study Results. Ann Thorac Cardiovasc Surg. 2011;17:19–23. doi: 10.5761/atcs.oa.09.01529. [DOI] [PubMed] [Google Scholar]
  • 11.Cadranel J, Quoix E, Baudrin L, Mourlanette P, Moro-Sibilot D, et al. IFCT-0401 Trial: a phase II study of gefitinib administered as first-line treatment in advanced adenocarcinoma with bronchioloalveolar carcinoma subtype. J Thorac Oncol. 2009;4:1126–1135. doi: 10.1097/JTO.0b013e3181abeb5d. [DOI] [PubMed] [Google Scholar]
  • 12.Travis WB, Brambilla A, Muller-Hermelinck HK, et al. WHO histological classification of tumours of the lung. World Health Organization Classification of Tumours. 2004. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC Press 2004. p10. Lyon, France.
  • 13.Bhatia R, Lopipero P, Smith AH. Diesel exhaust exposure and lung cancer. Epidemiology. 1998;9:84–91. [PubMed] [Google Scholar]
  • 14.Tang N, Wu Y, Ma J, Wang B, Yu R. Coffee consumption and risk of lung cancer: a meta-analysis. Lung Cancer. 2010;67:17–22. doi: 10.1016/j.lungcan.2009.03.012. [DOI] [PubMed] [Google Scholar]
  • 15.Vida S, Pintos J, Parent ME, Lavoué J, Siemiatycki J. Occupational exposure to silica and lung cancer: pooled analysis of two case-control studies in Montreal, Canada. Cancer Epidemiol Biomarkers Prev. 2010;19:1602–1611. doi: 10.1158/1055-9965.EPI-10-0015. [DOI] [PubMed] [Google Scholar]
  • 16.Akira M, Atagi S, Kawahara M, Iuchi K, Johkoh T. High-resolution CT findings of diffuse bronchioloalveolar carcinoma in 38 patients. AJR Am J Roentgenol. 1999;173:1623–1629. doi: 10.2214/ajr.173.6.10584811. [DOI] [PubMed] [Google Scholar]
  • 17.Wislez M, Antoine M, Baudrin L, Poulot V, Neuville A, et al. Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib. Lung Cancer. 2010;68:185–191. doi: 10.1016/j.lungcan.2009.05.021. [DOI] [PubMed] [Google Scholar]
  • 18.Harpole DH, Bigelow C, Young WG, Jr, Wolfe WG, Sabiston DC., Jr Alveolar cell carcinoma of the lung: a retrospective analysis of 205 patients. Ann Thorac Surg. 1988;46:502–507. doi: 10.1016/s0003-4975(10)64685-1. [DOI] [PubMed] [Google Scholar]
  • 19.Lee HY, Lee KS, Han J, Kim BT, Cho YS, et al. Mucinous versus nonmucinous solitary pulmonary nodular bronchioloalveolar carcinoma: CT and FDG PET findings and pathologic comparisons. Lung Cancer. 2009;65:170–175. doi: 10.1016/j.lungcan.2008.11.009. [DOI] [PubMed] [Google Scholar]
  • 20.Carretta A, Canneto B, Calori G, Ceresoli GL, Campagnoli E, et al. Evaluation of radiological and pathological prognostic factors in surgically-treated patients with bronchoalveolar carcinoma. Eur J Cardiothorac Surg. 2001;20:367–371. doi: 10.1016/s1010-7940(01)00733-3. [DOI] [PubMed] [Google Scholar]
  • 21.Okubo K, Mark EJ, Flieder D, Wain JC, Wright CD, et al. Bronchoalveolar carcinoma: clinical, radiologic, and pathologic factors and survival. J Thorac Cardiovasc Surg. 1999;118:702–709. doi: 10.1016/S0022-5223(99)70016-4. [DOI] [PubMed] [Google Scholar]
  • 22.Furák J, Troján I, Szoke T, Tiszlavicz L, Morvay Z, et al. Bronchioloalveolar lung cancer: occurrence, surgical treatment and survival. Eur J Cardiothorac Surg. 2003;23:818–823. doi: 10.1016/s1010-7940(03)00084-8. [DOI] [PubMed] [Google Scholar]
  • 23.Hsiung CA, Lan Q, Hong YC, Chen CJ, Hosgood HD, et al. The 5p15.33 locus is associated with risk of lung adenocarcinoma in never-smoking females in Asia. PLoS Genet. 2010;6:e1001051. doi: 10.1371/journal.pgen.1001051. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Pao W, Miller V, Zakowski M, Doherty J, Politi K, et al. EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA. 2004;101:13306–13311. doi: 10.1073/pnas.0405220101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Leroux C, Cruz JCM, Mornex JF. SRLVs: A genetic continuum of lentiviral species in sheep and goats with cumulative evidence of cross species transmission. Curr HIV Res. 2010;8:94–100. doi: 10.2174/157016210790416415. [DOI] [PubMed] [Google Scholar]
  • 26.Boffetta P, Gridley G, Gustavsson P, Brennan P, Blair A, et al. Employment as butcher and cancer risk in a record-linkage study from Sweden. Cancer Causes Control. 2000;11:627–633. doi: 10.1023/a:1008947531573. [DOI] [PubMed] [Google Scholar]
  • 27.Rai SK, DeMartini JC, Miller AD. Retrovirus vectors bearing Jaagsiekte Sheep Retrovirus Env transduce human cells by using a new receptor localized to chromosome 3p21.3. J Virol. 2000;74:4698–4704. doi: 10.1128/jvi.74.10.4698-4704.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Rai SK, Duh FM, Vigdorovich V, Danilkovitch-Miagkova A, Lerman MI, et al. Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation. Proc Natl Acad Sci USA. 2001;98:4443–4448. doi: 10.1073/pnas.071572898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Dirks C, Duh FM, Rai SK, Lerman MI, Miller AD. Mechanism of cell entry and transformation by enzootic nasal tumor virus. J Virol. 2002;76:2141–2149. doi: 10.1128/jvi.76.5.2141-2149.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.De las Heras M, Barsky SH, Hasleton P, Wagner M, Larson E, et al. Evidence for a protein related immunologically to the jaagsiekte sheep retrovirus in some human lung tumours. Eur Respir J. 2000;16:330–332. doi: 10.1034/j.1399-3003.2000.16b23.x. [DOI] [PubMed] [Google Scholar]
  • 31.Rocca S, Sanna MP, Leoni A, Cossu A, Lissia A, et al. Presence of Jaagsiekte sheep retrovirus in tissue sections from human bronchioloalveolar carcinoma depends on patients' geographical origin. Hum Pathol. 2008;39:303–304. doi: 10.1016/j.humpath.2007.10.008. [DOI] [PubMed] [Google Scholar]
  • 32.Morozov VA, Lagaye S, Lower J, Lower R. Detection and characterization of betaretroviral sequences, related to sheep Jaagsiekte virus, in Africans from Nigeria and Cameroon. Virology. 2004;327:162–168. doi: 10.1016/j.virol.2004.05.028. [DOI] [PubMed] [Google Scholar]
  • 33.Yousem SA, Finkelstein SD, Swalsky PA, Bakker A, Ohori NP. Absence of jaagsiekte sheep retrovirus DNA and RNA in bronchioloalveolar and conventional human pulmonary adenocarcinoma by PCR and RT-PCR analysis. Hum Pathol. 2001;32:1039–1042. doi: 10.1053/hupa.2001.28249. [DOI] [PubMed] [Google Scholar]
  • 34.Boffetta P, Mannetje A, Zaridze D, Szeszenia-Dabrowska N, Rudnai P, et al. Occupational X-ray examinations and lung cancer risk. Int J Cancer. 2005;115:263–267. doi: 10.1002/ijc.20854. [DOI] [PubMed] [Google Scholar]

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES